CAN news

A Novel Treatment May Help Reduce the Progression of Alzheimer’s Disease

Of all the neurodegenerative diseases, Alzheimer’s disease (AD) stands as the most common worldwide. While the onset is complex in nature, a hallmark sign of illness is the accumulation of a particular peptide in the brain, known as amyloid beta (Aβ) (http://www.jci.org/articles/view/25100). When present, the molecule can aggregate to form plaques and also interact with cells in the brain leading to altered signalling and function.